Business Context and Reporting Period
Company: Dyadic International, Inc.
Filing Type: Form 8-K
Date of Report: December 19, 2005
Event: Entry into a Material Definitive Agreement and Termination of a prior Cooperation Agreement.
On December 19, 2005, Dyadic International, Inc. and its subsidiaries (Dyadic-Florida and Dyadic NL) entered into a Termination and License Agreement with TNO (Netherlands Organisation for Applied Scientific Research) and its subsidiary TNO Bedrijven B.V. This agreement terminated a Cooperation Agreement dated August 12, 2003, which governed the development of a fungal high throughput robotic screening system (Fungal HTRS System).
Key Financial Metrics and Transaction Details
This filing reports a specific transaction rather than periodic financial performance. Key financial elements include:
- Debt Settlement: The agreement satisfied all indebtedness of Dyadic NL to TNO, including a trade payable for research services of approximately $377,000.
- Consideration Paid: Dyadic issued 161,560 shares of fully paid and non-assessable Common Stock (par value $.001) to TNO Bedrijven B.V.
- Financial Obligations Eliminated: The transaction cancelled TNO's royalty interest on revenues, operating profit interest, gain interest on asset sales, and a stock option to purchase Dyadic-Florida shares at $4.50 per share.
- Liquidity Impact: The filing does not provide specific cash flow or liquidity metrics for the company as a whole, only the settlement of the specific $377,000 liability via stock issuance.
Material Changes Versus Prior Period
The primary material change is the restructuring of the relationship with TNO regarding the Fungal HTRS System:
- Termination of Profit Sharing: The previous arrangement requiring Dyadic to share royalties, net profits, and sale proceeds with TNO has been eliminated.
- License Conversion: TNO's technology license was converted into a paid-up, exclusive, worldwide license for Dyadic to use TNO technology in the Fungal HTRS field.
- Debt Elimination: The $377,000 trade payable previously owed to TNO has been extinguished.
- Continuity: The long-term relationship for research and development on Dyadic's C1 Host Technology is expected to continue, with TNO remaining a "Preferred Supplier" for research services on a favored pricing basis.
Guidance, Outlook, and Risks
Management Commentary: Management states the Termination Agreement effectively eliminates the profit-sharing and royalty rights arrangement with TNO related to the HTRS system. The agreement is expected to have no negative effect on the long-term R&D relationship.
Risks and Contingencies:
- Restricted Securities: The 161,560 shares issued to TNO are unregistered restricted securities under the Securities Act of 1933.
- Registration Rights: TNO has been granted "piggyback registration" rights for a two-year period to include these shares in any future registration statement filed by Dyadic.
- Arbitration: The agreement retains binding arbitration provisions for commercial disputes under the rules of the International Chamber of Commerce in London.
Important Facts for Investor Verification
- Verify the exact number of shares issued (161,560) and the resulting dilution impact on existing shareholders.
- Confirm the elimination of the $377,000 liability and the removal of future royalty and profit-sharing obligations to TNO.
- Review the "piggyback registration" rights granted to TNO, which may affect future capital raising activities.
- Assess the continued reliance on TNO as a "Preferred Supplier" for R&D services and the terms of the favored pricing basis.
- Examine the attached Termination and License Agreement (Exhibit 99.1) for specific covenants regarding the right of first offer on non-fungal HTRS systems.